New Mountain Capital to acquire Machinify and combine with leading healthcare intelligence and payment platform
Acquiring Company
53-asset net lease portfolio
Acquired Company
Machinify
Description
New Mountain Capital, LLC has announced a definitive agreement to acquire Machinify, Inc. Machinify will become a core part of the company formed through the merger of The Rawlings Group, Apixio’s Payment Integrity business, and VARIS. The combined organization, to be named Machinify at close, will bring together revolutionary technology, clinical expertise, and a wealth of data to transform healthcare payments and build a frictionless foundation for healthcare administration for all stakeholders.
Quick answer
53-asset net lease portfolio is acquiring Machinify, announced January 10, 2025. 53-asset net lease portfolio is based in New York, New York, United States.
- How much did 53-asset net lease portfolio pay for Machinify?
- The deal value was not disclosed.
- What does 53-asset net lease portfolio do?
- The net lease portfolio consists of preexisting long-term leases with 11 institutional-quality tenants, spanning 16 states in the US, as well as additional assets in Canada, the UK, and Germany.
- Where are 53-asset net lease portfolio and Machinify based?
- 53-asset net lease portfolio is based in New York, New York, United States. Machinify is based in Palo Alto, California, United States.
Source: Fundz verified event record.
Other recent acquisitions in Investment Management and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- ActiGraph completes acquisition of Biofourmis Connect to enhance digital health solutions (January 7, 2025)
- GSK completes acquisition of IDRx, Inc. to enhance precision therapeutics for treating gastrointestinal stromal tumours (February 24, 2025)
- New Mountain Capital, LLC acquires Machinify, Inc. to revolutionize healthcare payments (February 20, 2025)
- Flourish Research acquires Diablo Clinical Research to expand therapeutic coverage (February 18, 2025)
- Novartis to acquire Anthos Therapeutics for up to $3.1 Billion, $3.1B (February 11, 2025)
- Pan-Am Dental completes strategic acquisitions of JB Dental Lab and Avaneer Dental Studio, solidifying its position as a top 10 dental lab group (February 10, 2025)
Who to call at 53-asset net lease portfolio, and when
When 53-asset net lease portfolio changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day 53-asset net lease portfolio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at 53-asset net lease portfolio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at 53-asset net lease portfolio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment 53-asset net lease portfolio makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Machinify?
Machinify was acquired by 53-asset net lease portfolio, based in New York. The deal was reported on January 10, 2025. The net lease portfolio consists of preexisting long-term leases with 11 institutional-quality tenants, spanning 16 states in the US, as well as additional assets in Canada, the UK, and Germany. 53-asset net lease portfolio is privately held and operates in Investment Management.
When did 53-asset net lease portfolio acquire Machinify?
53-asset net lease portfolio's acquisition of Machinify was reported on January 10, 2025. New Mountain Capital, LLC has announced a definitive agreement to acquire Machinify, Inc. Machinify will become a core part of the company formed through the merger of The Rawlings Group, Apixio’s Payment Integrity business, and VARIS. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Machinify do?
It is privately held, operating in Biotechnology, and is based in Palo Alto.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.